BIOBIJOU Co.,Ltd. (KOSDAQ:489460)

South Korea · Delayed Price · Currency is KRW

11,390

+440 (4.02%)

At close: Aug 11, 2026

-38.17% (1Y)

Market Cap	171.36B -38.2%
Revenue (ttm)	24.92B -27.8%
Net Income	5.35B -30.2%
EPS	362.62 -44.7%
Shares Out	15.04M
PE Ratio	31.41
Forward PE	n/a
Dividend	100.00 (0.91%)
Ex-Dividend Date	n/a

Volume	96,026
Open	10,950
Previous Close	10,950
Day's Range	10,870 - 11,400
52-Week Range	5,230 - 18,500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About BIOBIJOU

BIOBIJOU Co.,Ltd. engages in the research, development, manufacturing, and sale of skin booster and filler products in South Korea. It offers cosmetic products which includes skin boosters which is used in treatment to improve skin condition using microneedle therapy system; medical devices include hyaluronic acid dermal fillers under the COLENA PREMIUM and CANDORLOV brand name; and pharmaceuticals, such as include botulinum toxin. It also exports its products to Iraq, the Dominican Republic, Turkey, China, Vietnam, Hong Kong, Russia, Malaysia,... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2018

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 489460

Full Company Profile

Financial Performance

In 2025, BIOBIJOU's revenue was 28.49 billion, a decrease of -3.86% compared to the previous year's 29.63 billion. Earnings were 4.15 billion, a decrease of -42.24%.

Financial Statements